Disease Activity Patterns, Mortality, and Colorectal Cancer Risk in Microscopic Colitis: A Danish Nationwide Cohort Study, 2001 to 2016
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Disease Activity Patterns, Mortality, and Colorectal Cancer Risk in Microscopic Colitis : A Danish Nationwide Cohort Study, 2001 to 2016. / Weimers, Petra; Ankersen, Dorit Vedel; Lophaven, Søren; Bonderup, Ole Kristian; Münch, Andreas; Løkkegaard, Ellen Christine Leth; Munkholm, Pia; Burisch, Johan.
I: Journal of Crohn's and Colitis, Bind 15, Nr. 4, 2021, s. 594-602.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Disease Activity Patterns, Mortality, and Colorectal Cancer Risk in Microscopic Colitis
T2 - A Danish Nationwide Cohort Study, 2001 to 2016
AU - Weimers, Petra
AU - Ankersen, Dorit Vedel
AU - Lophaven, Søren
AU - Bonderup, Ole Kristian
AU - Münch, Andreas
AU - Løkkegaard, Ellen Christine Leth
AU - Munkholm, Pia
AU - Burisch, Johan
N1 - Publisher Copyright: © 2020 The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn's and Colitis Organisation. All rights reserved.
PY - 2021
Y1 - 2021
N2 - Background and Aims: The disease course of microscopic colitis [MC], encompassing collagenous colitis [CC] and lymphocytic colitis [LC], is not well known. In a Danish nationwide cohort, we evaluated the disease activity patterns as well as the risk of colorectal cancer [CRC] and mortality based on disease severity. Methods: All incident MC patients [n=14 302] with a recorded diagnosis of CC [n=8437] or LC [n=5865] in the Danish Pathology Register, entered between 2001 and 2016, were matched to 10 reference individuals [n=142 481]. Incident cases of CRC after the index date were captured from the Danish Cancer Registry. Mortality data were ascertained from the Danish Registry of Causes of Death, and information about treatment was obtained from the Danish National Prescription Registry. The risk of CRC and mortality analyses were investigated by Cox regression and Kaplan-Meier estimates. Results: We identified a self-limiting or transient disease course in 70.6% of LC patients and in 59.9% of CC patients, p<0.001. Less than 5% of MC patients experienced a budesonide-refractory disease course and were treated with immunomodulators or biologic treatment. A total of 2926 [20.5%] MC patients and 24 632 [17.3%] reference individuals died during the study period. MC patients with a severe disease had a relative risk [RR] of mortality of 1.41 (95% confidence interval [CI]: 1.32-1.50) compared with reference individuals. Only 90 MC patients were diagnosed with CRC during follow-up, corresponding to an RR of 0.48 [95% CI: 0.39-0.60]. Conclusions: A majority of MC patients experience an indolent disease course with a lower risk of developing CRC compared with the background population.
AB - Background and Aims: The disease course of microscopic colitis [MC], encompassing collagenous colitis [CC] and lymphocytic colitis [LC], is not well known. In a Danish nationwide cohort, we evaluated the disease activity patterns as well as the risk of colorectal cancer [CRC] and mortality based on disease severity. Methods: All incident MC patients [n=14 302] with a recorded diagnosis of CC [n=8437] or LC [n=5865] in the Danish Pathology Register, entered between 2001 and 2016, were matched to 10 reference individuals [n=142 481]. Incident cases of CRC after the index date were captured from the Danish Cancer Registry. Mortality data were ascertained from the Danish Registry of Causes of Death, and information about treatment was obtained from the Danish National Prescription Registry. The risk of CRC and mortality analyses were investigated by Cox regression and Kaplan-Meier estimates. Results: We identified a self-limiting or transient disease course in 70.6% of LC patients and in 59.9% of CC patients, p<0.001. Less than 5% of MC patients experienced a budesonide-refractory disease course and were treated with immunomodulators or biologic treatment. A total of 2926 [20.5%] MC patients and 24 632 [17.3%] reference individuals died during the study period. MC patients with a severe disease had a relative risk [RR] of mortality of 1.41 (95% confidence interval [CI]: 1.32-1.50) compared with reference individuals. Only 90 MC patients were diagnosed with CRC during follow-up, corresponding to an RR of 0.48 [95% CI: 0.39-0.60]. Conclusions: A majority of MC patients experience an indolent disease course with a lower risk of developing CRC compared with the background population.
KW - collagenous colitis
KW - colorectal cancer
KW - lymphocytic colitis
KW - Microscopic colitis
KW - mortality
KW - population-based cohort
U2 - 10.1093/ecco-jcc/jjaa207
DO - 10.1093/ecco-jcc/jjaa207
M3 - Journal article
C2 - 33049029
AN - SCOPUS:85104046919
VL - 15
SP - 594
EP - 602
JO - Journal of Crohn's & colitis
JF - Journal of Crohn's & colitis
SN - 1873-9946
IS - 4
ER -
ID: 301139415